Statements, 2011

GAVI Alliance expresses its deep appreciation for an increase in funding secured in the Fiscal Year 2012 omnibus spending bill passed by the US Congress on 17 December.

CEO Seth Berkley says that GAVI stands ready to play its role in achieving a world with zero new HIV infections and zero AID-s related deaths.

Rotavirus-related diarrhoea kills mostly in developing countries, but vaccine roll outs have begun.

Feared for centuries because of the death and paralysis it causes, polio is finally on the edge of eradication.

The Malian Government has fully reimbursed GAVI the amount of US$ 563,000 that was misused during the period 2008-2010.

New results published today in the New England Journal of Medicine about a large-scale Phase III trial conducted in seven African countries of the malaria vaccine candidate RTS,S deserve a hearty round of applause.

The GAVI Alliance congratulates Liberian President Ellen Johnson Sirleaf on winning the Nobel Peace Prize.

UN Inter-agency report says prioritisation needed on tackling major killers of children such as pneumonia and diarrhoea

GAVI Alliance partners do not expect any major disruption in 2011 to supplies of pentavalent vaccines following today’s announcement by the World Health Organization (WHO) that it has delisted “Easyfive,” a pentavalent vaccine produced by Panacea Biotec.

In keeping with GAVI s policy on transparency in the oversight of cash-based programmes, its Deputy CEO recently updated the GAVI Board on the status of cash-based programmes in Zambia.

Every year, 600,000 people die from hepatitis B-related causes, the most serious type of viral hepatitis and a major cause of liver cancer. [German].

GAVI Alliance supports African introduction of rotavirus vaccines against the leading cause of severe infant diarrhoea.

Review commends GAVI’s critical work in providing life saving vaccines to children in the poorest countries, and for offering Australia a “proven, respected and innovative multilateral mechanism for further developing its interest in supporting countries in Africa, while at the same time minimizing the risk of aid fragmentation.”

The GAVI Alliance applauds J.P. Morgan for its leadership and generosity in donating 1.5 million to a new Matching Fund for Immunisation.

Developing nations are making increasing financial commitments to the cost of childhood immunisation, a key foundation for social and economic development, the GAVI Alliance said ahead of a pledging conference on 13 June. [German]

An investigation by the GAVI Alliance has concluded that US$ 563,000 was misused in two of its cash-based programmes in Mali.

Managing Director, Programme Delivery, GAVI Alliance, Mercy Ahun, delivers a speech during the World Health Assembly, highlighting GAVI's contribution to the WHO's 'Global Immunization Vision and Strategy'.

Statement by GAVI Alliance Board Chair, Dagfinn Høybräten.

Statement by the GAVI Alliance interim CEO, Helen Evans.

Statement by the GAVI Alliance interim CEO, Helen Evans.

Statement by the GAVI Alliance interim CEO, Helen Evans.

Saving the life of even one small child is always a big success. As we celebrate this year’s immunisation week, which begins on 23 April, we congratulate the World Health Organisation and all GAVI Alliance partners on the millions of child lives saved through immunisation.

Alex Palacios, GAVI Special Representative, delivers statement before the House Appropriations Sub-committee on State and Foreign Operations, United States House of Representatives Washington DC.

Pneumococcal vaccines introduced in seventh GAVI-eligible country.

To further increase transparency of the oversight of its cash-based support, the GAVI Alliance announced today that it will make public when it suspends a cash programme to investigate possible misuse of funds.

Joint statement by GAVI Alliance Board Chair Dagfinn Høybråten and IFFIm Board Chair Alan Gillespie. Japanese 

GAVI and UICC (Union for International Cancer Control) join forces on International Women’s Day, 8 March 2011, to call for rapid introduction of anti-cancer vaccine.